Long-term trends in cardiovascular disease mortality and association with respiratory disease

Epidemiology and Infection

Volumn 144, Issue 4, 2016, Pages 777-786

  Mercer, A J ^a  

^a NONE   (United Kingdom)

Author keywords

Cardiovascular; cerebrovascular; heart disease; influenza; respiratory disease

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; BRONCHITIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR DISEASE; CHLAMYDIA PNEUMONIAE; DISEASE ASSOCIATION; HELICOBACTER PYLORI; HUMAN; INFLUENZA; INTERNATIONAL CLASSIFICATION OF DISEASES; PNEUMONIA; RESPIRATORY TRACT DISEASE; SEASONAL INFLUENZA; SMOKING; SOCIAL STATUS; TREND STUDY; UNITED STATES; ADOLESCENT; ADULT; AGED; CHILD; ENGLAND; EPIDEMIOLOGY; HEART DISEASE; INFANT; MIDDLE AGED; MORTALITY; NEWBORN; PRESCHOOL CHILD; TRENDS; VERY ELDERLY; WALES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; ENGLAND; HEART DISEASES; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; MORTALITY; RESPIRATORY TRACT DISEASES; WALES; YOUNG ADULT;

EID: 84961725660     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268815001818     Document Type: Article

References (91)

1. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Statistics Quarterly 1988; 41: 155-178.
2. De Looper M, Bhatia K. International Health-How Australia Compares. Canberra: Australian Institute of Health and Welfare, 1998.
3. Levi F, et al. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002; 88: 119-124.
4. Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. European Heart Journal 2006; 27: 107-113.
5. McKee M. The health consequences of the collapse of the Soviet Union. In: Leon D, Walt G, eds. Poverty, Inequality and Health: An International Perspective. Oxford: Oxford University Press, 2001, pp. 17-36.
6. Mirzaei M, et al. Coronary heart disease epidemics: not all the same. Heart 2009; 95: 740-746.
7. National Heart Lung and Blood Institute. Report of the Task Force on Research in Epidemiology and Prevention of Cardiovascular Diseases. Rockville, Maryland: National Institutes of Health, 1994.
8. Marmot MG, et al. Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet 1997; 350: 235-239.
9. Marmot MG, et al. Changing social-class distribution of heart diseases. BritishMedical Journal 1978; 2: 1109-1112.
10. Mackenbach JP, et al. Geographic variation in the onset of decline of male ischaemic heart disease mortality in the Netherlands. American Journal of Public Health 1989; 79: 1621-1627.
11. Gale CR, Martyn CN. The conundrum of time trends in stroke. Journal of the Royal Society of Medicine 1997; 90: 138-143.
12. Whisnant JP. The decline of stroke. Stroke 1984; 15: 160-168.
13. La Vecchia C, Levi F. Trends in cerebrovascular mortality in western and eastern Europe. European Neurology 1994; 34: 301-305.
14. Centers for Disease Control. Achievements in public health, 1900-1999: decline in deaths from heart disease and stroke-United States, 1900-1999. Morbidity and Mortality Weekly Report 1999; 48: 649-656.
15. Bonita R, Beaglehole R. Increased treatment of hypertension does not explain the decline in stroke mortality in the United States, 1970-1980. Hypertension 1989; 3 (5 Suppl.): I-69-I-73.
16. Haberman S, Capideo R, Rose FC. Diverging trends in cerebrovascular disease and ischaemic heart disease mortality. Stroke 1982; 13: 582-589.
17. Walker WJ. Changing United States life-style and declining vascular mortality: cause or coincidence? New England Journal of Medicine 1977; 297: 163-165.
18. Stamler J. The marked decline in coronary heart disease mortality rates in the United States, 1968-1981; summary of findings and possible explanations. Cardiology 1985; 72: 11-22.
19. Kannel WB, Thom TJ. Declining cardiovascular mortality. Circulation 1984; 70: 331-336.
20. Goldman L, Cook E. The decline in ischaemic heart disease mortality rates: an analysis of the comparative effects of medical interventions and changes in lifestyle. Annals of Internal Medicine 1984; 101: 825-836.
21. Huninck MG, et al. The recent decline in mortality from coronary heart disease, 1980-1990: The effect of secular trends in risk factors and treatment. Journal of the American Medical Association 1997; 277: 535-542.
22. Ford ES, et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. New England Journal of Medicine 2007; 356: 2388-2398.
23. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004; 109: 1101-1107.
24. Bots ML, Grobbe DE. Decline of coronary heart disease mortality in the Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors. Journal of Cardiovascular Risk 1996; 3: 271-276.
25. Bjorck L, et al. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. European Heart Journal 2009; 30: 1046-1056.
26. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 1999; 81: 380-386.
27. Capewell S, et al. Explaining the decline in mortality from coronary heart disease in Auckland, New Zealand between 1982 and 1993. Circulation 2000; 102: 1511-1516.
28. Burch GE, Giles TD. The role of viruses in the production of heart disease. American Journal of Cardiology 1972; 29: 231-239.
29. Lu Wan Ching. Agglutination of human platelets by influenza PR8 strain virus and mumps virus. Federation Proceedings 1958; 17: 446.
30. Mustard JF. Platelets and thromboembolic disease. Advances in Cardiology 1970; 4: 131-142.
31. Genton E, Wiley HS, Steele PP. Platelets, thrombosis and coronary artery disease. Advances in Cardiology 1973; 9: 29-39.
32. Mustard JF, et al. Platelets and atherosclerosis. Journal of Atherosclerosis Research 1964; 4: 1-28.
33. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proceedings of the National Academy of Sciences USA 1973; 70: 1753-1756.
34. Nieto FJ. Infections and atherosclerosis: New clues from an old hypothesis? American Journal of Epidemiology 1998; 148: 937-947.
35. Morré SA, et al. Microorganisms in the aetiology of atherosclerosis. Journal of Clinical Pathology 2000; 53: 647-654.
36. Campbell LA, Kuo C, Grayston JT. Chlamydia pneumoniae and cardiovascular disease. Emerging Infectious Diseases 1998; 4: 571-579.
37. Ngeh J, Anand V, Gupta S. Chlamydia pneumoniae and atherosclerosis-what we know and what we don't know. Clinical Microbiology and Infection 2002; 8: 2-13.
38. Patel P, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. British Medical Journal 1995; 311: 711-714.
39. Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease-A possible trigger for acute myocardial infarction? International Journal of Epidemiology 1978; 7: 231-239.
40. Fleming DM, Cross KW, Pannell RS. Influenza and its relationship to circulatory disorders. Epidemiology and Infection 2005; 133: 255-262.
41. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review. Lancet Infectious Diseases 2009; 9: 601-610.
42. Markus HS, Mendall MA. Helicobacter pylori infection: A risk factor for ischaemic cerebrovascular disease and carotid atheroma. Journal of Neurology, Neurosurgery and Psychiatry 1998; 64: 104-107.
43. Grau AJ, et al. Recent infection as a risk factor for cerebrovascular ischaemia. Stroke 1995; 26: 373-379.
44. Mercer A, Infections, Chronic Disease, and the Epidemiological Transition. A New Perspective. Rochester Studies in Medical History. Rochester NY: University of Rochester Press, 2014.
45. Clayton DG, Taylor D, Shaper AG. Trends in heart disease in England and Wales, 1950-73. Health Trends 1977; 9: 1-6.
46. Nikiforov SV, Mamaev VB. The development of sex differences in cardiovascular disease mortality: A historical perspective. American Journal of Public Health 1998; 88: 1348-1353.
47. Registrar General for England andWales. Annual Report for England and Wales, 1875-1899; Annual Statistical Review for England and Wales, 1900-. London: HMSO.
48. Office for National Statistics, UK Statistics Authority. Twentieth Century Mortality. CD-ROM. Newport, Wales: Office for National Statistics; Norwich: Stationery Office Books, 2004.
49. European Commission, Eurostat. Revision of the European Standard Population. Luxembourg: Publications Office of the European Union, 2013.
50. Janssen F, Kunst AE. ICD coding changes and discontinuities in trends in cause-specific mortality in six European countries, 1950-99. Bulletin of the World Health Organisation 2004; 82: 904-913.
51. Centers for Disease Control and Prevention. Comparability of Cause-of-death Between ICD Revisions. Table for selected causes. National Center for Health Statistics, United States (www.cdc.gov/nchs/data/dvs/comp2.pdf).
52. Griffiths C, Brock A. 20th century mortality trends in England and Wales. Health Statistics Quarterly 2003; 18: 5-17.
53. Waldron HA, Vickerstaff L. Intimations of Quality: Ante Mortem and Post Mortem Diagnoses. London: Nuffield Provincial Hospitals Trust, 1977.
54. Charlton J, et al. Cardiovascular diseases. In: Charlton J, Murphy M, eds. The Health of Adult Britain 1841-1994, Volume 2. London: The Stationery Office, 1997, pp. 60-81.
55. Marks G, Burney P. Diseases of the respiratory system. In: Charlton J, Murphy M, eds. The Health of Adult Britain 1841-1994, Volume 2. London: The Stationery Office, 1997, pp 93-113.
56. Doll R, et al. Mortality in relation to smoking: 50 years' observations on male British doctors. British Medical Journal 2004; 328: 1519-1533.
57. Preston SH. International comparisons of excessive adult mortality. Population Studies 1970; 24: 5-20.
58. Retherford RD. The Changing Sex Differential in Mortality. Studies in Population and Urban Demography No. 1. Connecticut: Greenwood, 1975.
59. Aaby P, et al. Severe measles in Sunderland, 1885: A European-African comparison of causes of severe infection. International Journal of Epidemiology 1986; 15: 101-107.
60. Aaby P, et al. Overcrowding and intensive exposure as determinants of measles mortality. American Journal of Epidemiology 1984; 120: 49-63.
61. Gardner G, Frank AL, Taber LH. Effects of social and family factors on viral respiratory infection and illness in the first year of life. Journal of Epidemiology and Community Health 1984; 38: 42-48.
62. Berman S. Epidemiology of acute respiratory infections in children in developing countries. Reviews of Infectious Diseases 1991; 13 (Suppl. 6): S454-462.
63. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. Journal of Pediatrics 2003; 143 (5 Suppl.): S118-126.
64. Burnett J. Housing and the decline in mortality. In Schofield RD, Reher D, Bideau A, eds. The Decline of Mortality in Europe. Oxford: Clarendon Press, 1991.
65. Mercer AJ. Relative trends in mortality from related respiratory and airborne infectious diseases. Population Studies 1986; 40: 129-145.
66. Brimblecombe FSW, et al. Family studies of respiratory infections. British Medical Journal 1958; 1: 119-128.
67. Longini IM, et al. Estimating household and community transmission parameters for influenza. American Journal of Epidemiology 1982; 115: 736-751.
68. Alling DW, Blackwelder WC, Stuart-Harris CH. A study of excess mortality during influenza epidemics in the United States, 1968-1976. American Journal of Epidemiology 1981; 113: 30-42.
69. Reichert TA, et al. Influenza and the winter increase in mortality in the United States, 1959-1999. American Journal of Epidemiology 2004; 160: 492-502.
70. Tillett HE, Smith JWG, Gooch CD. Excess deaths attributable to influenza in England and Wales: age at death and certified cause. International Journal of Epidemiology 1983; 12: 344-352.
71. Stocks P. The effect of influenza epidemics on the certified causes of death. Lancet 1934; 2: 1331-1340.
72. Bull GM. Meteorological correlates with myocardial and cerebral infarction and respiratory diseases. British Journal of Preventive and Social Medicine 1973; 27: 108-113.
73. West RR, Lloyd S, Roberts CJ. Mortality from ischaemic heart diseases: association with the weather. British Journal of Preventive and Social Medicine 1973; 27: 36-40.
74. Madjid M, et al. Influenza and cardiovascular disease-is there a causal relationship? Texas Heart Institute Journal 2004; 31: 4-13.
75. Ross R. Atherosclerosis-an inflammatory disease. New England Journal of Medicine 1999; 340: 115-125.
76. Karbasi-Afshar R, Khedmat H, Izadi M. Helicobacter pylori infection and atherosclerosis: A systematic review. Acta Medica Iranica 2015; 53: 78-88.
77. Kalayoglu MV, Libby P, Byrne GI. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. Journal of the American Medical Association 2002; 288: 2724-2731.
78. Kiechl S, et al. Chronic infections and the risk of carotid atherosclerosis. Circulation 2001; 103: 1064-1070.
79. Heltai K, et al. Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease. Atherosclerosis 2004; 173: 339-346.
80. Smeeth L, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. New England Journal of Medicine 2004; 351: 2611-2618.
81. Danesh J, et al. Low grade inflammation and coronary heart disease: prospective study and updated metaanalyses. British Medical Journal 2000; 321: 199-204.
82. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430-436.
83. Wald NJ, et al. Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study. British Medical Journal 2000; 321: 204-207.
84. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infectious Diseases 2010; 10: 83-92.
85. Madjid M. Acute infections, vaccination and prevention of cardiovascular disease. Canadian Medical Association Journal 2008; 179: 749-750.
86. Reichert TA, et al. The Japanese experience with vaccinating schoolchildren against influenza. New England Journal of Medicine 2001; 344: 889-896.
87. Reichert TA, Sharma A. The seasonability of human mortality: The role of influenza. International Congress Series 2001; 1219: 95-101.
88. Madjid M, et al. Influenza and cardiovascular disease. A new opportunity for prevention and the need for further studies. Circulation 2003; 108: 2730-2736.
89. Keller T, et al. Influenza vaccines for preventing coronary heart disease. Cochrane Database of Systematic Reviews 2008. Issue 3, Art. No.: CD005050. doi: 10.1002/14651858.CD005050.pub2.
90. Lamontagne F, et al. Pneumonococcal vaccination and risk of myocardial infarction. Canadian Medical Association Journal 2008; 179: 773-777.
91. Beaglehole R. Poverty and human development: The global implications of cardiovascular disease. Circulation 2007; 116: 1871-1873.